Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer

Basic & Clinical Pharmacology & Toxicology
Henrik GréenCurt Peterson

Abstract

The purpose of this study was to evaluate the role of sequence variants in the CYP2C8, ABCB1 and CYP3A4 genes and the CYP3A4 phenotype for the pharmacokinetics and toxicity of paclitaxel in ovarian cancer patients. Thirty-eight patients were treated with paclitaxel and carboplatin. The genotypes of CYP2C8*1B, *1C, *2, *3, *4, *5, *6, *7, *8 and P404A, ABCB1 G2677T/A and C3435T, as well as CYP3A4*1B, were determined by pyrosequencing. Phenotyping of CYP3A4 was performed in vivo with quinine as a probe. The patients were monitored for toxicity and 23 patients underwent a more extensive neurotoxicity evaluation. Patients heterozygous for G/A in position 2677 in ABCB1 had a significantly higher clearance of paclitaxel than most other ABCB1 variants. A lower clearance of paclitaxel was found for patients heterozygous for CYP2C8*3 when stratified according to the ABCB1 G2677T/A genotype. In addition, the CYP3A4 enzyme activity in vivo affected which metabolic pathway was dominant in each patient, but not the total clearance of paclitaxel. The exposure to paclitaxel correlated to the degree of neurotoxicity. Our findings suggest that interindividual variability in paclitaxel pharmacokinetics might be predicted by ABCB1 and CYP2C8 geno...Continue Reading

References

Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L BergF M Balis
Jan 1, 1995·Cancer Chemotherapy and Pharmacology·G KumarK Bhalla
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L GianniM J Egorin
Nov 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M T HuizingJ H Beijnen
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M T HuizingJ H Beijnen
Jan 1, 1997·Journal of Clinical Pharmacology·K T Kivistö, H K Kroemer
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·A SparreboomO van Tellingen
Dec 1, 1999·Clinical Pharmacology and Therapeutics·R A MirghaniL L Gustafsson
Apr 25, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·R A MirghaniL L Gustafsson
Aug 15, 2001·Clinical Pharmacology and Therapeutics·R B KimG R Wilkinson
Jun 18, 2002·Molecular Pharmacology·Chava Kimchi-SarfatyMichael M Gottesman
Oct 31, 2002·Advanced Drug Delivery Reviews·Jatinder K LambaKenneth E Thummel
May 14, 2003·European Journal of Clinical Pharmacology·Rajaa A MirghaniLeif Bertilsson
Jun 5, 2003·Biochemical Pharmacology·Naomi MoritaKazuo Nakayama
Aug 2, 2003·Pharmacogenetics·Deanna L KroetzUNKNOWN Pharmacogenetics of Membrane Transporters Investigators
Oct 10, 2003·Clinical Pharmacology and Therapeutics·Mikko NiemiPertti J Neuvonen
Jan 30, 2004·Clinical Pharmacology and Therapeutics·Catia MarzoliniRichard B Kim
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Akiko SoyamaJun-ichi Sawada
Jan 19, 2005·Journal of Pharmacological Sciences·Ryoko TaniguchiShinichi Kobayashi
Feb 18, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hiroyuki HichiyaJun-ichi Sawada
May 20, 2005·Journal of Clinical Pharmacology·Miki NakajimaTsuyoshi Yokoi
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephan MielkeKlaus Mross
Sep 21, 2005·Biochemical and Biophysical Research Communications·Cristina Rodríguez-AntonaMagnus Ingelman-Sundberg
Nov 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anja HenningssonHoward L McLeod
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Henrik GréenCurt Peterson
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H YamaguchiJ Goto
Sep 5, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tristan M SissungStephan Mielke
Jan 17, 2007·The Pharmacogenomics Journal·S MarshT W Synold
Oct 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharon MarshRobert Brown
Feb 1, 2006·Personalized Medicine·Sharon Marsh

❮ Previous
Next ❯

Citations

Mar 10, 2010·The Pharmacogenomics Journal·S LeskeläC Rodríguez-Antona
Feb 16, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D L HertzE C Dees
May 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T J PostmaJ J Heimans
Dec 15, 2010·Pharmacogenetics and Genomics·Connie OshiroRuss Altman
Jun 19, 2013·Journal of Medical Genetics·Luis J Leandro-GarcíaCristina Rodríguez-Antona
Jun 22, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Luis J Leandro-GarcíaCristina Rodríguez-Antona
Jun 3, 2011·The Oncologist·Maarten J DeenenJan H M Schellens
Sep 19, 2009·Pharmacogenomics·Elizabeth B Daily, Christina L Aquilante
Apr 27, 2010·Pharmacogenomics·Cristina Rodríguez-Antona
Apr 28, 2011·Pharmacogenomics·Cristina Rodríguez-Antona, Henrik Gréen
Jul 11, 2013·Pharmacogenomics·Daniel L Hertz
Feb 18, 2011·European Journal of Clinical Pharmacology·Troels K BergmannCurt Peterson
Sep 2, 2014·Biological & Pharmaceutical Bulletin·Yuji MukaiNobuo Inotsume
Mar 30, 2013·Annales pharmaceutiques françaises·V ZabaletaJ M Irache
Aug 25, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Martin N FranssonHenrik Gréen
Jul 2, 2011·The Lancet Oncology·Guido CavalettiPaola Marmiroli
Jan 23, 2010·Pharmacology & Therapeutics·Beshay N M Zordoky, Ayman O S El-Kadi
Nov 10, 2009·Biochemical Pharmacology·Sarah J HemauerMahmoud S Ahmed
Sep 22, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M AgüerosJ M Irache
Nov 21, 2015·Cancer Treatment Reviews·C N FrederiksE Boven
Oct 1, 2011·Basic & Clinical Pharmacology & Toxicology·Troels K BergmannKim Brøsen
Jun 24, 2015·Critical Reviews in Oncology/hematology·M P WeenC Ricciardelli
May 26, 2015·Critical Reviews in Oncology/hematology·Francesca De IuliisSusanna Scarpa
Nov 27, 2014·Basic & Clinical Pharmacology & Toxicology·Yuji MukaiNobuo Inotsume
Aug 14, 2015·BioData Mining·Cielito C Reyes-GibbySanjay Shete
Jun 27, 2015·Pharmacogenomics·Mi-Young LeeMagnus Ingelman-Sundberg
Jul 17, 2015·Cancer Cell International·Khalid O AlfaroukCyril Rauch
Apr 17, 2015·BMC Pharmacology & Toxicology·Sandrina LambrechtsUNKNOWN Belgian and Luxembourg Gynaecological Oncology Group (BGOG)
Dec 17, 2014·Pharmacogenomics·Virginia BosóSalvador F Aliño
Oct 4, 2013·Pharmacogenomics·Gregorio Antonio Alcazar-GonzálezHugo Alberto Barrera-Saldaña
Apr 6, 2017·Clinical Pharmacology and Therapeutics·Y ZhouV M Lauschke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.